SEC Form 4 · accession 0001562180-17-002202
Intersect ENT, Inc. · XENT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dana G Mead Jr.
Director
Period of report
Jun 1, 2017
Accepted (ET)
Jun 5, 2017 · 7:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001271214
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 1, 2017 | A | 2,546 | $0.00 | A | 8,242 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to buy)F2 | $26.05 | Jun 1, 2017 | A | 6,035 | A | — | May 31, 2027 | Common Stock | 6,035 | 6,035 | D |
Explanation of responses
- F1Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan. Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting. The restricted stock units vest one year from grant date on June 1, 2018.
- F2The shares subject to the option vest in 12 equal monthly installments commencing on June 1, 2017.